| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas
|
Liu, Ziru
|
|
|
|
7 |
p. 1346-1355
|
artikel
|
| 2 |
Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale
|
Furuya, Daisuke
|
|
2019
|
|
7 |
p. 871-875
|
artikel
|
| 3 |
A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables
|
Miyake, Makito
|
|
|
|
7 |
p. 1364-1376
|
artikel
|
| 4 |
An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma
|
Sun, Yanwu
|
|
|
|
7 |
p. 1299-1307
|
artikel
|
| 5 |
A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015)
|
Nishimura, Yasumasa
|
|
|
|
7 |
p. 1250-1259
|
artikel
|
| 6 |
A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width
|
Bozkaya, Yakup
|
|
2019
|
|
7 |
p. 798-806
|
artikel
|
| 7 |
Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study
|
Batra, Ullas
|
|
|
|
7 |
p. 1221-1228
|
artikel
|
| 8 |
Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab
|
Nakamura, Kazutaka
|
|
|
|
7 |
p. 913-921
|
artikel
|
| 9 |
Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib
|
Watanabe, Daichi
|
|
|
|
7 |
p. 1257-1263
|
artikel
|
| 10 |
Atypical oncologic failure after laparoscopic and robot-assisted radical cystectomy at a single institution
|
Kubota, Masashi
|
|
|
|
7 |
p. 1385-1392
|
artikel
|
| 11 |
Benefit of intensive chemotherapy for elderly patients aged 80 years or older with metastatic colorectal cancer: a state-wide multicenter cohort study
|
Nakayama, Yujiro
|
|
|
|
7 |
p. 1248-1256
|
artikel
|
| 12 |
Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety
|
Tanioka, Hiroaki
|
|
2019
|
|
7 |
p. 836-841
|
artikel
|
| 13 |
Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis
|
Choi, Kyu Hye
|
|
|
|
7 |
p. 1405-1411
|
artikel
|
| 14 |
Central statistical monitoring of investigator-led clinical trials in oncology
|
Buyse, Marc
|
|
|
|
7 |
p. 1207-1214
|
artikel
|
| 15 |
Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma
|
Motai, Risa
|
|
|
|
7 |
p. 1188-1195
|
artikel
|
| 16 |
Clinical significance of thermal detection of soft-tissue tumors
|
Shimatani, Akiyoshi
|
|
|
|
7 |
p. 1418-1424
|
artikel
|
| 17 |
Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
|
Aogi, Kenjiro
|
|
|
|
7 |
p. 1229-1236
|
artikel
|
| 18 |
Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer
|
Miyake, Hideaki
|
|
2019
|
|
7 |
p. 842-847
|
artikel
|
| 19 |
Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer
|
Sato, Kentaro
|
|
|
|
7 |
p. 1272-1284
|
artikel
|
| 20 |
Computed tomography findings for predicting the future occurrence of pancreatic cancer: value of pancreatic volumetry
|
Kawaji, Yuki
|
|
|
|
7 |
p. 1304-1313
|
artikel
|
| 21 |
Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study
|
Hou, Guangdong
|
|
|
|
7 |
p. 1356-1363
|
artikel
|
| 22 |
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
|
Aogi, Kenjiro
|
|
|
|
7 |
p. 1237
|
artikel
|
| 23 |
Correction to: Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy
|
Iwasa, Satoru
|
|
|
|
7 |
p. 1233
|
artikel
|
| 24 |
Dawn of precision medicine on gastric cancer
|
Ishii, Takahiro
|
|
2019
|
|
7 |
p. 779-788
|
artikel
|
| 25 |
Discrimination between breast invasive ductal carcinomas and benign lesions by optimizing quantitative parameters derived from dynamic contrast-enhanced MRI using a semi-automatic method
|
Yang, Jiawen
|
|
2019
|
|
7 |
p. 815-824
|
artikel
|
| 26 |
Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study
|
Shimada, Muneaki
|
|
|
|
7 |
p. 1314-1321
|
artikel
|
| 27 |
Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma
|
Lin, Zhongyang
|
|
|
|
7 |
p. 1260-1269
|
artikel
|
| 28 |
Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer
|
Suzuki, C.
|
|
|
|
7 |
p. 1270-1277
|
artikel
|
| 29 |
Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors
|
Teranishi, Ryugo
|
|
|
|
7 |
p. 1164-1172
|
artikel
|
| 30 |
Efficacy and safety of 188Re-HEDP in lung cancer patients with bone metastases: a randomized, multicenter, multiple-dose phase IIa study
|
Chen, Ping
|
|
|
|
7 |
p. 1212-1220
|
artikel
|
| 31 |
Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial
|
Kamata, Ken
|
|
|
|
7 |
p. 1196-1201
|
artikel
|
| 32 |
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study
|
Iguchi, Taro
|
|
2019
|
|
7 |
p. 848-856
|
artikel
|
| 33 |
Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database
|
Qi, Wei-xiang
|
|
|
|
7 |
p. 1203-1211
|
artikel
|
| 34 |
Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer
|
Sumii, Atsuhiko
|
|
|
|
7 |
p. 1173-1179
|
artikel
|
| 35 |
Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
|
Zheng, Hongjuan
|
|
|
|
7 |
p. 1145-1153
|
artikel
|
| 36 |
Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma
|
Lyu, Zhuozhen
|
|
|
|
7 |
p. 1334-1345
|
artikel
|
| 37 |
External validation of the "optimal PSA follow-up schedule after radical prostatectomy” in a new cohort
|
Yanai, Yoshinori
|
|
|
|
7 |
p. 1393-1397
|
artikel
|
| 38 |
High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan
|
Yazaki, S.
|
|
|
|
7 |
p. 1327-1333
|
artikel
|
| 39 |
High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer
|
Batbayar, Chingunjav
|
|
|
|
7 |
p. 901-912
|
artikel
|
| 40 |
Implementation of a molecular tumor board at a regional level to improve access to targeted therapy
|
Bourien, Héloïse
|
|
|
|
7 |
p. 1234-1241
|
artikel
|
| 41 |
Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer
|
Okano, Susumu
|
|
2019
|
|
7 |
p. 789-797
|
artikel
|
| 42 |
Inflammation–nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma
|
Ni, Xiao-Chun
|
|
2019
|
|
7 |
p. 825-835
|
artikel
|
| 43 |
Jab1/Cops5: a promising target for cancer diagnosis and therapy
|
Yuan, Chunjue
|
|
|
|
7 |
p. 1159-1169
|
artikel
|
| 44 |
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
|
Naito, Yoichi
|
|
|
|
7 |
p. 827-840
|
artikel
|
| 45 |
Laboratory prognostic score for predicting 14-day mortality in terminally ill patients with gynecologic malignancy
|
Onishi, Kazuma
|
|
|
|
7 |
p. 1345-1352
|
artikel
|
| 46 |
Longitudinal health-related quality of life analysis in childhood cancer survivors after proton beam therapy
|
Fukushima, Hiroko
|
|
|
|
7 |
p. 928-939
|
artikel
|
| 47 |
Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma
|
Yamamoto, Yoko
|
|
2019
|
|
7 |
p. 863-870
|
artikel
|
| 48 |
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study
|
Nakamichi, Shinji
|
|
|
|
7 |
p. 872-879
|
artikel
|
| 49 |
Management and outcome of pediatric Wilms tumor with malignant inferior Vena cava thrombus: largest cohort of single-center experience
|
Elayadi, Moatasem
|
|
|
|
7 |
p. 1425-1431
|
artikel
|
| 50 |
Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells
|
Oue, Naohide
|
|
2019
|
|
7 |
p. 771-778
|
artikel
|
| 51 |
Molecular targeted drugs, comprehensive classification and preclinical models for the implementation of precision immune oncology in hepatocellular carcinoma
|
Shimada, Shu
|
|
|
|
7 |
p. 1101-1109
|
artikel
|
| 52 |
Muscle strength and functional recovery for soft-tissue sarcoma of the thigh: a prospective study
|
Tanaka, Atsushi
|
|
|
|
7 |
p. 922-927
|
artikel
|
| 53 |
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
|
Kudo, Masatoshi
|
|
|
|
7 |
p. 1110-1119
|
artikel
|
| 54 |
Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer
|
Kajiyama, Hiroaki
|
|
2019
|
|
7 |
p. 857-862
|
artikel
|
| 55 |
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients
|
Watanuki, Rurina
|
|
2019
|
|
7 |
p. 807-814
|
artikel
|
| 56 |
Otorhinolaryngologists/head and neck surgeons’ knowledge, attitudes, and practices regarding fertility preservation in young cancer patients treated with chemotherapy: an anonymous questionnaire survey
|
Akisada, Naoki
|
|
|
|
7 |
p. 1196-1202
|
artikel
|
| 57 |
Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia
|
Cao, Yang
|
|
|
|
7 |
p. 1222-1232
|
artikel
|
| 58 |
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801
|
Hosokawa, Shinobu
|
|
|
|
7 |
p. 1139-1144
|
artikel
|
| 59 |
Performance of Idylla™RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer
|
Makutani, Yusuke
|
|
|
|
7 |
p. 1180-1187
|
artikel
|
| 60 |
Performance of three prognostic models in critically ill patients with cancer: a prospective study
|
Martos-Benítez, Frank D.
|
|
|
|
7 |
p. 1242-1249
|
artikel
|
| 61 |
Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)
|
Ohta, Takashi
|
|
|
|
7 |
p. 1291-1298
|
artikel
|
| 62 |
Phase II study of S-1-based sequential combination chemotherapy including oxaliplatin plus bevacizumab and irinotecan with or without cetuximab for metastatic colorectal cancer: the SOBIC trial
|
Nakamoto, Yoshihiko
|
|
|
|
7 |
p. 1285-1290
|
artikel
|
| 63 |
Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer
|
Matsuoka, Hiroya
|
|
|
|
7 |
p. 1318-1326
|
artikel
|
| 64 |
Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy
|
Iwasa, Satoru
|
|
|
|
7 |
p. 1223-1232
|
artikel
|
| 65 |
Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy
|
Kano, Satoshi
|
|
|
|
7 |
p. 1179-1187
|
artikel
|
| 66 |
Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases
|
Yasunaga, Masafumi
|
|
|
|
7 |
p. 1330-1335
|
artikel
|
| 67 |
Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis
|
Feng, Shaofang
|
|
|
|
7 |
p. 1127-1138
|
artikel
|
| 68 |
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study
|
Sakai, Daisuke
|
|
|
|
7 |
p. 1154-1163
|
artikel
|
| 69 |
Recent advances in surgical techniques for breast reconstruction
|
Tomita, Koichi
|
|
|
|
7 |
p. 841-846
|
artikel
|
| 70 |
Recent advances of the regulation roles of MicroRNA in glioblastoma
|
Yan, Chengrui
|
|
|
|
7 |
p. 1215-1222
|
artikel
|
| 71 |
Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study
|
Yao, Zichuan
|
|
|
|
7 |
p. 1377-1384
|
artikel
|
| 72 |
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study
|
Kato, Takeshi
|
|
|
|
7 |
p. 1238-1247
|
artikel
|
| 73 |
Serum LOX-1 is a novel prognostic biomarker of colorectal cancer
|
Nakashima-Nakasuga, Chiyo
|
|
|
|
7 |
p. 1308-1317
|
artikel
|
| 74 |
Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer
|
Morizane, Shuichi
|
|
|
|
7 |
p. 1398-1404
|
artikel
|
| 75 |
Spread of lymph node metastasis and adjuvant therapy for distal cholangiocarcinoma
|
Kurahara, Hiroshi
|
|
|
|
7 |
p. 1212-1221
|
artikel
|
| 76 |
Surgical outcomes of early-stage primary vaginal nonsquamous cell carcinoma
|
Nomura, Hidetaka
|
|
|
|
7 |
p. 1412-1417
|
artikel
|
| 77 |
Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma
|
Suzuki, Kazuhiro
|
|
|
|
7 |
p. 1322-1329
|
artikel
|
| 78 |
Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: a 20-year review at a single institution
|
Inaka, Yuko
|
|
|
|
7 |
p. 1170-1178
|
artikel
|
| 79 |
Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes
|
Matsukane, Ryosuke
|
|
|
|
7 |
p. 860-871
|
artikel
|
| 80 |
The carcinoembryonic antigen ratio is a potential predictor of survival in recurrent colorectal cancer
|
Suzuki, Yumi
|
|
|
|
7 |
p. 1264-1271
|
artikel
|
| 81 |
The Geriatric Nutritional Risk Index is a prognostic marker in patients with metastatic colorectal cancer
|
Kato, Rikako
|
|
|
|
7 |
p. 893-900
|
artikel
|
| 82 |
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy
|
Takeda, Tsuyoshi
|
|
|
|
7 |
p. 1293-1303
|
artikel
|
| 83 |
The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis
|
Hamura, Ryoga
|
|
|
|
7 |
p. 1188-1195
|
artikel
|
| 84 |
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
|
Akamatsu, Hiroaki
|
|
2019
|
|
7 |
p. 731-770
|
artikel
|
| 85 |
The roles and limitations of bevacizumab in the treatment of ovarian cancer
|
Nakai, Hidekatsu
|
|
|
|
7 |
p. 1120-1126
|
artikel
|
| 86 |
Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study
|
Hu, Yixuan
|
|
|
|
7 |
p. 880-892
|
artikel
|
| 87 |
Trends and issues in clinical research on satisfaction and quality of life after mastectomy and breast reconstruction: a 5-year scoping review
|
Saiga, Miho
|
|
|
|
7 |
p. 847-859
|
artikel
|
| 88 |
Tumor budding as a predictive marker for 5-fluorouracil response in adjuvant-treated stage III colorectal cancer
|
Akabane, Shintaro
|
|
|
|
7 |
p. 1285-1292
|
artikel
|
| 89 |
Urinalysis by combination of the dipstick test and urine protein–creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer
|
Masaki, Chie
|
|
|
|
7 |
p. 1278-1284
|
artikel
|
| 90 |
Use of direct oral anti-coagulants for the treatment of venous thromboembolism in patients with advanced cancer: a prospective observational study
|
Oyakawa, Takuya
|
|
2019
|
|
7 |
p. 876-881
|
artikel
|
| 91 |
Utility of whole brain radiation therapy for leptomeningeal carcinomatosis
|
Hirano, Yasuhiro
|
|
|
|
7 |
p. 1432-1439
|
artikel
|
| 92 |
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
|
Miyagi, Etsuko
|
|
|
|
7 |
p. 1336-1344
|
artikel
|
| 93 |
What has changed in malignant mesothelioma between 1990 and 2019? A time- series analyses in Turkey
|
Metintas, Selma
|
|
|
|
7 |
p. 1202-1211
|
artikel
|
Tijdschrift beschrijving